NextCure (NXTC) Other Non Operating Income (2018 - 2026)
NextCure's Other Non Operating Income was $73,000 in Q3 2026, down 77.3% from $321,000 a year earlier and down 63.9% from the prior quarter.
NextCure (NXTC) Other Non Operating Income (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, NextCure's Other Non Operating Income was $905,000 through Sep 30, 2026, down 60.7% year-over-year; for FY2025, it came in at $1.77 million, down 56.7% from FY2024.
- Other Non Operating Income shows a five-year compound annual growth rate of -17.4% (FY2020 to FY2025).
- In earlier years, Other Non Operating Income was $4.09 million in FY2024 (-16.7%), $4.91 million in FY2023 (+317.9%), $1.18 million in FY2022 (-14.5%) and $1.38 million in FY2021 (-70.2%).
- The Q3 2026 figure marks the lowest quarterly Other Non Operating Income since Q2 2021.
- Compared with a year earlier, Other Non Operating Income has declined for ten straight quarters, with an average decline of 56.7% over the last eight quarters.
- The best year-over-year quarter for Other Non Operating Income over five years was Q2 2023 (growth of 524.5%); the worst was Q4 2021 (a decline of 83.0%).
- Per Business Quant data, NXTC's Other Non Operating Income in the three quarters before Q3 2026 was $202,000 (Q2 2026), $309,000 (Q1 2026) and $321,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | NextCure | 29.30 Mn | -71.08 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 73,000.00 |
| Jun 30, 2026 | 202,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 321,000.00 |
| Sep 30, 2025 | 321,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | 646,000.00 |
| Dec 31, 2024 | 852,000.00 |
| Sep 30, 2024 | 955,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 975,000.00 |
| Dec 31, 2022 | 471,000.00 |
| Sep 30, 2022 | 328,000.00 |
| Jun 30, 2022 | 208,000.00 |
| Mar 31, 2022 | 169,000.00 |
| Dec 31, 2021 | 132,000.00 |
NextCure Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=NXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();